Propolis Carnosic Acid Synergistic Composition Candidiasis Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for candidiasis, particularly caused by Candida species such as C. albicans, are ineffective due to the limited efficacy of existing antifungal agents and the lack of a comprehensive, multitargeted strategy, with existing products often being unilateral and segmented in their approach, failing to address the disease comprehensively.
Innovation Solution
A synergistic composition comprising propolis with a polyphenol concentration between 70 and 90% by weight and carnosic acid, concentrated at more than 70%, is used to prevent and treat candidiasis in humans and animals, offering a molecular and multitargeted approach by combining the antimicrobial and antioxidant properties of both components.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antifungal agents are used, then treatment is provided, but effectiveness is limited due to unilateral and segmented approach
Solution Approach 1:
The patent combines propolis and carnosic acid into a single synergistic composition that addresses multiple disease mechanisms simultaneously. Propolis provides broad-spectrum antimicrobial activity while carnosic acid contributes antioxidant and anti-inflammatory effects, creating a unified treatment that overcomes the limitations of single-agent therapies.
Solution Approach 2:
The synergistic composition performs multiple functions: antimicrobial action against Candida species, antioxidant protection, anti-inflammatory effects, and modulation of immune response. This multi-functional approach allows a single composition to address various aspects of candidiasis pathology that conventional single-purpose agents cannot achieve.
2Reliability
If existing antifungal products are used, then some treatment effect is achieved, but they fail to address the disease comprehensively
Solution Approach 1:
The patent employs a composite formulation combining propolis (a natural resinous substance) and carnosic acid (a phenolic compound). This composite material leverages the complementary properties of both components, where propolis provides structural complexity and broad antimicrobial activity while carnosic acid adds targeted antioxidant and anti-inflammatory capabilities, achieving comprehensive treatment without excessive complexity.
3Reliability
If single-component treatments are used, then simplicity is maintained, but molecular synergy is not achieved
Solution Approach 1:
The patent merges propolis and carnosic acid in specific proportions to achieve synergistic antifungal effects. The combination leverages the antimicrobial properties of propolis with the antioxidant and membrane-disrupting effects of carnosic acid, creating a enhanced treatment effect that exceeds the sum of individual components while maintaining a manageable two-component structure.
Data Source
AI summary
Synergistic composition comprising propolis and carnosic acid for use in the prevention and treatment of candidiasis. The invention relates to a synergistic composition comprising propolis that comprises polyphenols at a concentration between 70 and 90% by weight of propolis and carnosic acid, for use in the prevention and treatment of candidiasis in humans and/or animals. The invention also relates to a synergistic pharmaceutical and/or veterinary composition and a synergistic food product.